Clinical Testing News and Research

RSS

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Pulse oximetry: A 50-year-old device gets an upgrade

A portable device used to detect blood oxygen levels revolutionized the medical field 50 years ago and is now receiving essential updates

7 Jul 2023

Wastewater surveillance highlights significant underestimation of COVID-19 cases in Canada

Research examines the correlation between SARS-CoV-2 levels in untreated water and COVID-19 cases and hospitalizations in Ontario, Canada. It also highlights the value of wastewater data in enhancing local decision-making and COVID-19 surveillance systems.

3 Jul 2023

Novel drug combination shows promise in treating pancreatic cancer

Mutations in the KRAS gene are the major driver of pancreatic cancer. The resulting protein controls multiple signaling pathways involved in cell growth and survival. In cancer, the gene is mutated to be permanently "on," driving cells to excessively multiply and form tumors.

28 Jun 2023

New hope for cystic fibrosis patients as groundbreaking treatment enters clinical trial

Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in people with CF who cannot benefit from current therapies.

26 Jun 2023

Molecular cargo released by cancer cells lays the groundwork for leukemia spread

Tiny packets of molecular cargo shed by cancer cells seed the foundations for metastasis at distant sites in the body.

19 Jun 2023

MGI and AddLife AB Announce Strategic Collaboration for Expanded Distribution of MGI products* in the Nordic Region

MGI Tech Co. Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, are delighted to announce a comprehensive collaboration with AddLife AB, one of Europe's largest distributors of clinical testing and laboratory equipment, headquartered in Stockholm.

From MGI 16 Jun 2023

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

Researchers performed an observational study to determine the prevalence of germline genetic testing among all patients aged 20 years or older diagnosed with cancer between January 1, 2013, and March 31, 2019, in two United States, California and Georgia.

8 Jun 2023

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.

1 Jun 2023

First-in-human clinical trial of liver dialysis device successfully completed

The first successful in-patient trial of liver dialysis* has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators.

31 May 2023

A more aggressive FTC is starting to target drug mergers and industry middlemen

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration's push for lower drug prices at the pharmacy counter.

22 May 2023

Humanized mouse model for rare genetic disease developed for the first time

Mice with a defected human gene responsible for a rare genetic disease, called congenital adrenal hyperplasia, have been developed for the first time.

15 May 2023

Can artificial intelligence help predict the risk of pancreatic cancer using disease trajectories?

Researchers designed surveillance programs for the early detection of patients at elevated risk of pancreatic cancer.

10 May 2023

New type of oral capsule for diabetics could mean pain-free delivery of insulin

Scientists in Melbourne have designed a new type of oral capsule that could mean pain-free delivery of insulin and other protein drugs.

19 Apr 2023

The importance and challenges of developing mucosal SARS-COV-2 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2.

13 Apr 2023

Using brain organoids to test gene therapies for a rare disease in children

Brain tissue grown in a laboratory by University of Queensland researchers will be used to test a treatment for a rare disease in children and help unlock therapies for a range of neurological disorders.

5 Apr 2023

New system leverages the sensing capabilities of a smartphone to measure blood glucose levels

According to the U.S. Centers for Disease Control, one out of every three adults in the United States has prediabetes, a condition marked by elevated blood sugar levels that could lead to the development of Type 2 diabetes.

31 Mar 2023

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

In this interview, NewsMedical speaks with Dr. Yuying Wang, R&D Director (Oncology), from BGI Genomics, about colorectal cancer and the development and application of COLOTECT® 1.0, a non-invasive fecal DNA test for the detection of colorectal cancer and pre-cancerous lesions.

From BGI Genomics 27 Mar 2023